US Blood Pressure Monitoring Devices Market Size, Share, and Trends 2024 to 2033

U.S. Blood Pressure Monitoring Devices Market (By Product: Digital Blood Pressure Monitor, Sphygmomanometer, Ambulatory Blood Pressure Monitor, Instruments & Accessories, Transducers; By End User: Ambulatory Surgical Centers & Clinics, Hospitals, Home Healthcare) - Regional Outlook and Forecast 2024 to 2033

  • Last Updated : February 2024
  • Report Code : 3735
  • Category : Healthcare

The U.S. blood pressure monitoring devices market size was valued at USD 0.52 billion in 2023 and is anticipated to reach around USD 1.48 billion by 2033, expanding at a double-digit CAGR of 11.10% from 2024 to 2033.

Blood Pressure Monitoring Devices Market Size in US 2024 To 2033

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

  • By product, the sphygmomanometer segment held the largest share of the market in 2023.
  • By product, the ambulatory blood pressure monitor segment is expected to witness the fastest rate of expansion during the forecast period of 2024-2033.
  • By end user, the hospitals segment held the largest share of the market in 2023 and the segment is observed to grow at the fastest rate during the forecast period.
  • By end user, the home healthcare segment is observed to grow at the fastest CAGR during the forecast period.

U.S. Blood Pressure Monitoring Devices Market Overview

The U.S. blood pressure monitoring devices market revolves around the development and distribution of monitoring devices that are generally to measure pulse inside the arteries using blood pressure as a parameter. To test, treat, and keep an eye on hypertension, blood pressure monitoring devices are essential. Pulse monitoring devices are incredibly accurate and assist physicians or other professionals in ensuring effective care. These incredibly accurate devices assist medical professionals in providing patients with efficient care.

Growth Factors

  • One important growth factor for the growth of the U.S. blood pressure monitoring devices market is the rising incidence of hypertension and associated cardiovascular disorders in the United States.
  • Devices for measuring blood pressure are in greater demand as more people receive high blood pressure diagnoses. The ageing of the world's population is yet another important element. Since hypertension is more common among the elderly, frequent blood pressure monitoring is essential. The U.S. blood pressure monitoring devices market is expanding due to this demographic trend.
  • The need for blood pressure monitors is driven by rising awareness of the value of routine medical exams and self-monitoring. Convenient and accurate solutions are sought after by health-conscious consumers.
  • In addition, the industry has been stimulated by the trend toward remote patient monitoring and at-home healthcare. These gadgets are being used by patients and healthcare professionals more and more for practical and economical health management.
  • Growing healthcare spending makes blood pressure monitors more accessible and affordable for a larger population, which propels the growth of the U.S. blood pressure monitoring devices market.
  • As technology continues to progress, creative and user-friendly blood pressure monitoring gadgets with wireless connectivity and smartphone integration have been created, increasing their market appeal.

U.S. Blood Pressure Monitoring Devices Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 11.10%
U.S. Market Size in 2023 USD 0.52 Billion
U.S. Market Size by 2033 USD 1.48 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product and By End User


U.S. Blood Pressure Monitoring Devices Market Dynamics

Driver

Rising older population and awareness about hypertension

The likelihood of hypertension seems to rise with age. Older people are more likely to have high blood pressure because of hormonal fluctuations and altered blood vessel flexibility. As a result, the need for blood pressure monitoring devices is being driven by the demographic trend toward an older population. Elderly people's blood pressure is being monitored and managed by healthcare practitioners more often with the prescription of these devices. Further boosting the U.S. blood pressure monitoring devices market’s expansion is the fact that a large number of senior citizens find home blood pressure monitoring to be more convenient.

Additionally, people are more likely to routinely check their blood pressure as they become more aware of the dangers of hypertension and how it affects their general health. Investing in personal blood pressure monitoring devices is encouraged by the focus on early identification and preventative healthcare. Furthermore, a greater number of prescriptions are being written as a result of healthcare professionals actively teaching patients about the advantages of monitoring. Device sales are fueled by this increased knowledge and health consciousness, which also improves health outcomes by enabling early intervention and lifestyle changes in reaction to rising blood pressure readings.

Restraint

The presence of high undiagnosed population

The greatest contributor to the burden of illnesses and the main cause of heart attacks is hypertension. A sizable segment of the populace received insufficient care or no diagnosis at all. As a result, they have a higher chance of morbidity and death from diseases like stroke and other CVDs that are associated with hypertension.

Healthcare professionals (HCPs) are encouraged to identify people who may have undetected hypertension as part of this effort. The new hypertension threshold, established by the American Heart Association (AHA) and the American College of Cardiology (ACC), is 130/80 mm Hg. It was 140/80 mm Hg before. Over 103 million Americans now have high blood pressure as a result of the reclassification. As a result, the large number of undiagnosed people poses a barrier to the expansion of the blood pressure monitoring device industry in the United States.

Opportunity

Rising demand for ambulatory blood pressure monitoring systems

Ambulatory blood pressure monitors are becoming more and more in demand, mainly for the diagnosis of white coats and disguised hypertension. Ambulatory blood pressure monitors are small, wrist- or arm-based devices with features that make them easier to use and more accessible. Ambulatory BP monitoring technologies allow for noninvasive blood pressure measurement. When people engage in regular activities, their blood pressure may be monitored by the use of ambulatory blood pressure monitors.

These gadgets keep an eye on how well blood pressure meds are working. The diagnosis of arterial hypertension is done at home and medical institutions like clinics using ambulatory blood pressure monitors. Advanced ambulatory blood pressure monitors are available from several companies. Thus, throughout the projected period, the U.S. blood pressure monitoring devices market will rise due to the rising demand for ambulatory BP monitoring systems.

Product Insights

The sphygmomanometer segment held the largest share of the U.S. blood pressure monitoring devices market in 2023 due to its accuracy and reliability. Sphygmomanometers are known for their accuracy in measuring blood pressure. This accuracy is crucial for making informed clinical decisions and diagnosing conditions such as hypertension. This remains a staple in clinical settings such as hospitals, clinics, and healthcare offices. They provide accurate blood pressure measurements and are often used by medical professionals to assess patients' cardiovascular health.

Besides, the ambulatory blood pressure monitor segment is expected to grow at the fastest CAGR during the forecast period. Ambulatory blood pressure monitor devices offer the advantage of continuous blood pressure monitoring, providing a more comprehensive and accurate picture of a patient's blood pressure variations throughout the day and night. This helps in identifying patterns and abnormalities that may go unnoticed with intermittent measurements.

Additionally, ABPM devices are designed to be portable and non-intrusive, allowing patients to go about their daily activities while the device records blood pressure readings at regular intervals. This ambulatory nature improves patient compliance and provides a more natural representation of their blood pressure.

End User Insights

The hospitals segment held the largest market share in 2023 and is expected to capture the largest market share during the forecast period. The large patient pool size is the reason for the high share. Increasingly, quick, accurate, and affordable diagnostic tools are needed to improve patient outcomes, which is why blood pressure monitoring devices are being used.

The home healthcare segment is expected to grow at the fastest rate over the projected period in the U.S. blood pressure monitoring devices market. home blood pressure monitoring devices offer convenience and accessibility, allowing individuals to monitor their blood pressure without the need for frequent visits to healthcare facilities. This is particularly beneficial for elderly individuals and those with mobility issues. Thereby, driving the segment expansion.

Recent Developments

  • In November 2023, the US Food and Drug Administration (FDA) authorized the Symplicity SpyralTM renal denervation (RDN) system, also referred to as the SymplicityTM blood pressure procedure, for the treatment of hypertension, according to a statement made by Medtronic plc, a pioneer in healthcare technology worldwide. Medtronic will start commercializing as soon as this permission is granted.
  • In August 2023, to address health disparities and lower the risk of heart attacks and strokes in underprivileged Detroit neighbourhoods, OMRON Healthcare, a pioneer in global heart health, and EPIC Health, Detroit's healthcare system dedicated to community-focused healthcare, launched a new partnership. Program participants will have access to VitalSightTM, OMRON's first remote patient monitoring service created exclusively for people with uncontrolled Stage 2 hypertension and other high blood pressure patients.

U.S. Blood Pressure Monitoring Devices Market Companies

  • Koninklijke Philips N.V.
  • General Electric Company
  • SunTech Medical, Inc.
  • Welch Allyn
  • American Diagnostic Corporation
  • Briggs Healthcare
  • Spacelabs Healthcare
  • GF HEALTH PRODUCTS, INC.
  • Rossmax International Limited
  • Microlife Corporation

Segments Covered in the Report

By Product

  • Digital Blood Pressure Monitor
    • Wrist
    • Arm
    • Finger
  • Sphygmomanometer
  • Ambulatory Blood Pressure Monitor
  • Instruments & Accessories
    • Blood pressure cuffs
      • Reusable
      • Disposable
    • Others
  • Transducers
    • Reusable
    • Disposable

By End User

  • Ambulatory Surgical Centers & Clinics
  • Hospitals
  • Home Healthcare

Frequently Asked Questions

The U.S. blood pressure monitoring devices market size is expected to increase USD 1.48 billion by 2033 from USD 0.52 billion in 2023.

The U.S. blood pressure monitoring devices market will register growth rate of 11.10% between 2024 and 2033.

The major players operating in the U.S. blood pressure monitoring devices market are Koninklijke Philips N.V., General Electric Company, SunTech Medical, Inc., Welch Allyn, American Diagnostic Corporation, Briggs Healthcare, Spacelabs Healthcare, GF HEALTH PRODUCTS, INC., Rossmax International Limited, Microlife Corporation, and Others.

The driving factors of the U.S. blood pressure monitoring devices market are the rising older population and awareness about hypertension.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Blood Pressure Monitoring Devices Market 

5.1. COVID-19 Landscape: U.S. Blood Pressure Monitoring Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8.U.S. Blood Pressure Monitoring Devices Market, By Product

8.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by Product, 2024-2033

8.1.1. Digital Blood Pressure Monitor

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Sphygmomanometer

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Ambulatory Blood Pressure Monitor

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Instruments & Accessories

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Transducers

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. U.S. Blood Pressure Monitoring Devices Market, By End User

9.1. U.S. Blood Pressure Monitoring Devices Market Revenue and Volume, by End User, 2024-2033

9.1.1. Ambulatory Surgical Centers & Clinics

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Hospitals

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Home Healthcare

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. U.S. Blood Pressure Monitoring Devices Market and Trend Forecast

10.1. U.S.

10.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

10.1.2. Market Revenue and Volume Forecast, by End User (2021-2033)

Chapter 11. Company Profiles

11.1. Koninklijke Philips N.V.

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. General Electric Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. SunTech Medical, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Welch Allyn

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. American Diagnostic Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Briggs Healthcare

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Spacelabs Healthcare

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. GF HEALTH PRODUCTS, INC.

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Rossmax International Limited

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Microlife Corporation

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 6000

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client